EP Patent

EP0240609A2 — Antibiotic A 40926 N-acylaminoglucuronyl aglycons and antibiotic A 40926 aglycon

Assigned to Gruppo Lepetit SpA · Expires 1987-10-14 · 39y expired

What this patent protects

The present invention concerns new antibiotic substances denominated antibiotic A 40926 N-acylamino­glucuronyl aglycon complex AB, antibiotic A 40926 N-acylaminoglucuronyl aglycon factor A, antibiotic A 40926 N-acylaminoglucuronyl aglycon factor B, antibiotic A 40926 N-acylaminog…

USPTO Abstract

The present invention concerns new antibiotic substances denominated antibiotic A 40926 N-acylamino­glucuronyl aglycon complex AB, antibiotic A 40926 N-acylaminoglucuronyl aglycon factor A, antibiotic A 40926 N-acylaminoglucuronyl aglycon factor B, antibiotic A 40926 N-acylaminoglucuronyl aglycon factor B₀, antibiotic A 40926 N-acylaminoglucuronyl aglycon factor B₁, antibiotic A 40926 aglycon and the addition salts thereof, a process for their preparation starting from antibiotic A 40926 complex or a factor thereof, and their use in the treatment of infectious diseases involving microorganisms susceptible to them.

Drugs covered by this patent

Patent Metadata

Patent number
EP0240609A2
Jurisdiction
EP
Classification
—
Expires
1987-10-14
Drug substance claim
No
Drug product claim
No
Assignee
Gruppo Lepetit SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.